Startups
Edit
GeneTex, Inc.
https://www.genetex.com/Research/Overview/infectious_diseasesLast activity: 10.01.2024
Active
Our facility provides large-scale antibody production capabilities and employs highly specific antigen affinity purification. This has facilitated the creation of a comprehensive antibody collection covering a wide spectrum of research fields.
Overview
Location
United States, California, Irvine
Employees
51-200
Phone
+1 949-553-1900
Founded date
1997
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 10, 2023 | Antimicrobial Susceptibility Testing Market Valued at USD 8.45 Billion by 2032, Driven by Rising Infectious Diseases | Reports And Data The antimicrobial susceptibility testing Market value for was USD 4.24 billion in 2022 and is expected to reach USD 8.45 billion in 2032 NEW YORK , NY, UNITED STATES, July 10, 2023/EINPresswire.com/ -- The antimicrobial sus... |
| Jun 15, 2022 | YCharOS adds Developmental Studies Hybridoma Bank (DSHB) to Industry Advisory Committee | YCharOS continues to expand Industry Advisory Committee and releases new open data Adding an academic partner shows the strength and flexibility of YCharOS’ open science framework.” — Dr. Aled EdwardsTORONTO, CANADA, June 15, 2022 /EINPress... |
| Mar 21, 2022 | YCharOS adds ABclonal Technology to Industry Advisory Committee | YCharOS continues to expand Industry Advisory Committee and releases new open data TORONTO, CANADA, March 21, 2022 /EINPresswire.com/ -- YCharOS Inc., an open science company with the mission of characterizing commercially available antibod... |
| Feb 24, 2020 | Karius, using liquid biopsy to detect infectious diseases, raises $165M in Series B round | The company plans to use the funding to expand its reach and also support future clinical studies. Karius is used in more than 100 hospitals and health systems around the country. It is designed to detect more than 1,000 bacteria, viruses, ... |
Reviews 0
FAQ about GeneTex, Inc.
When was GeneTex, Inc. founded?
GeneTex, Inc. was founded in 1997.
What has the press written about GeneTex, Inc.?
Parsers VC has collected 5 articles mentioning GeneTex, Inc., among them “Antimicrobial Susceptibility Testing Market Valued at USD 8.45 Billion by 2032, Driven by Rising Infectious Diseases” (Jul 10, 2023) and “YCharOS adds Developmental Studies Hybridoma Bank (DSHB) to Industry Advisory Committee” (Jun 15, 2022).
Is GeneTex, Inc. still active?
Yes, GeneTex, Inc. is active; its latest activity on Parsers VC dates from Jan 10, 2024.